The 10 most recent market catalysts affecting $OMDA, each scored for sentiment and estimated stock impact. Sourced from SEC EDGAR filings and financial news, analysed automatically as they are published.
Sep 11, 2026
Corporate Catalyst
Bullish
Impact 55
Barclays Maintains Overweight on Omada Health, Raises Price Target to $27
Barclays analyst Saket Kalia has maintained an 'Overweight' rating on Omada Health (OMDA) and raised the price target from $25 to $27. This action signals continued confidence from…
Aug 14, 2026
Corporate Catalyst
Bullish
Impact 60
JP Morgan Maintains Overweight on Omada Health, Raises Price Target to $30
JP Morgan analyst Lisa Gill maintained an 'Overweight' rating on Omada Health and raised the price target from $26 to $30. This indicates a strengthened positive outlook from a pro…
Aug 14, 2026
Corporate Catalyst
Bullish
Impact 55
Citizens Maintains Market Outperform on Omada Health, Raises Price Target to $32
Citizens analyst Constantine Davides has maintained a 'Market Outperform' rating on Omada Health (OMDA) and raised the price target from $27 to $32. This action signals increased c…
Aug 10, 2026
Corporate Catalyst
Bullish
Impact 55
BTIG Maintains Buy on Omada Health, Raises Price Target to $35
BTIG analyst David Larsen maintained a 'Buy' rating on Omada Health (OMDA) and raised the price target from $30 to $35. This indicates a continued bullish sentiment from the analys…
Aug 6, 2026
Corporate Catalyst
Bullish
Impact 75
Omada Health Raises FY2026 Sales Guidance from $322.000M-$330.000M to $334.000M-$340.000M vs $327.789M Est
Omada Health (OMDA) has raised its FY2026 sales guidance from $322M-$330M to $334M-$340M, significantly exceeding the analyst consensus of $327.789M. This upward revision indicates…
Aug 6, 2026
Corporate Catalyst
Bullish
Impact 92
Omada Health Q2 EPS $0.08 Beats $(0.01) Estimate, Sales $87.835M Beat $80.190M Estimate
Omada Health (OMDA) reported a substantial beat on both earnings and revenue for Q2. The company posted an EPS of $0.08, significantly exceeding the analyst consensus of a $(0.01) …
Aug 3, 2026
Corporate Catalyst
Bullish
Impact 55
Barclays Maintains Overweight on Omada Health, Raises Price Target to $25
Barclays analyst Saket Kalia maintaining an 'Overweight' rating and raising the price target for Omada Health from $20 to $25 is a positive signal for the company. This action sugg…
Jul 21, 2026
Corporate Catalyst
Bullish
Impact 55
Canaccord Genuity Maintains Buy on Omada Health, Raises Price Target to $28
Canaccord Genuity analyst Richard Close has maintained a 'Buy' rating on Omada Health (OMDA) and raised the price target from $24 to $28. This analyst action signals continued conf…
Jul 20, 2026
Corporate Catalyst
Bullish
Impact 55
Citizens Maintains Market Outperform on Omada Health, Raises Price Target to $27
Citizens analyst Constantine Davides has reiterated a 'Market Outperform' rating for Omada Health (OMDA) and raised the price target from $21 to $27. This action signals a strength…
Jul 17, 2026
Corporate Catalyst
Neutral
Impact 65
BTIG Initiates Coverage On Omada Health with Buy Rating, Announces Price Target of $30
BTIG's initiation of coverage on Omada Health with a 'Buy' rating and a $30 price target is a significant event for the company. Analyst coverage, especially with a positive rating…
Not financial advice. AI-generated analysis for informational purposes only. Tradow AI LLC is not a registered investment adviser.